| Primary Central Nervous System Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived50 of 50show fewer |
|---|
| → investigated in trials for | Methotrexatesmall molecule 26 trials (10 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 26 trials (11 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |